Hsu Jason 4
4 · Immix Biopharma, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Hsu Jason
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-15+21,587→ 21,587 totalExercise: $2.47From: 2024-05-15Exp: 2033-05-26→ Common Stock (21,587 underlying) - Award
Stock Option (Right to Buy)
2024-05-15+25,512→ 25,512 totalExercise: $2.47Exp: 2033-05-26→ Common Stock (25,512 underlying)
Holdings
- 813,000
Common Stock
- 3,915,913(indirect: See Footnote)
Common Stock
- 50,000(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein.
- [F2]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein.
- [F3]Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024.
- [F4]The Stock Option will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.